A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Conditions: Fibrodysplasia Ossificans Progressiva Sponsors: Ipsen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials